Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. Grob CS, et al. Arch Gen Psychiatry. 2011 Jan;68(1):71-8. doi: 10.1001/archgenpsychiatry.2010.116. Epub 2010 Sep 6. Arch Gen Psychiatry. 2011. PMID: 20819978 Clinical Trial.
Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs.
Halberstadt AL, Chatha M, Stratford A, Grill M, Brandt SD. Halberstadt AL, et al. Neuropharmacology. 2019 Jan;144:368-376. doi: 10.1016/j.neuropharm.2018.10.037. Epub 2018 Oct 29. Neuropharmacology. 2019. PMID: 30385253 Free PMC article.
Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD. Halberstadt AL, et al. Psychopharmacology (Berl). 2019 Feb;236(2):799-808. doi: 10.1007/s00213-018-5055-9. Epub 2018 Oct 8. Psychopharmacology (Berl). 2019. PMID: 30298278 Free PMC article.
Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.
Klein LM, Cozzi NV, Daley PF, Brandt SD, Halberstadt AL. Klein LM, et al. Neuropharmacology. 2018 Nov;142:231-239. doi: 10.1016/j.neuropharm.2018.02.028. Epub 2018 Feb 27. Neuropharmacology. 2018. PMID: 29499272 Free PMC article.
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).
Brandt SD, Kavanagh PV, Twamley B, Westphal F, Elliott SP, Wallach J, Stratford A, Klein LM, McCorvy JD, Nichols DE, Halberstadt AL. Brandt SD, et al. Drug Test Anal. 2018 Feb;10(2):310-322. doi: 10.1002/dta.2222. Epub 2017 Jul 27. Drug Test Anal. 2018. PMID: 28585392 Free PMC article.
Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
Halberstadt AL. Halberstadt AL. Curr Top Behav Neurosci. 2017;32:283-311. doi: 10.1007/7854_2016_64. Curr Top Behav Neurosci. 2017. PMID: 28097528 Review.
Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.
Wallach J, Kang H, Colestock T, Morris H, Bortolotto ZA, Collingridge GL, Lodge D, Halberstadt AL, Brandt SD, Adejare A. Wallach J, et al. PLoS One. 2016 Jun 17;11(6):e0157021. doi: 10.1371/journal.pone.0157021. eCollection 2016. PLoS One. 2016. PMID: 27314670 Free PMC article.
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Hoang K, Wallach J, Halberstadt AL. Brandt SD, et al. Drug Test Anal. 2016 Sep;8(9):891-902. doi: 10.1002/dta.1884. Epub 2015 Oct 12. Drug Test Anal. 2016. PMID: 26456305 Free PMC article.
65 results
Jump to page
Feedback